Effective market access strategies are the secret sauce for achieving gateways to customer adoption of your products. However, health plans often invoke prior authorizations on products for which they do not have outright positive coverage – and with a larger volume of specialty products and diagnostic procedures, life sciences organizations are facing prior authorizations for their products at an increasing rate. This additional step in product coverage poses severe challenges in getting these innovative products into the hands of patients and related challenges in reimbursement. So, how can organizations better prepare to handle this new volume of prior authorizations to ensure high levels of market access?
Listen to Baker Tilly’s and the Accreditation Council for Medical Affairs’ (ACMA) on-demand, informative session that discusses the challenges occurring in market access with a focus on prior authorizations and steps organizations can take to strategically address them through enhancement initiatives, accreditation measures and training programs. Our team of Value Architects™ discuss: